Histologic or immunohistochemical identification of immature precursor/blast cells (by antibodies against CD34 and KIT) is essential in identifying these cases, and to established the final diagnosis of hypoplastic MDS or hypoplastic AML (Figure 2A) [12,26]. The gene discussed is CD34; the disease is acute myeloid leukemia.